Skip to main content

Ester Del Barco Martínez

Institutions of which they are part

Maternal and Fetal Medicine
Vall Hebron Institut de Recerca
Ester Del Barco Martínez

Ester Del Barco Martínez

Ester Del Barco Martínez

Institutions of which they are part

Maternal and Fetal Medicine
Vall Hebron Institut de Recerca

Projects

Manejo de los fetos con retraso de crecimiento intrauterino precoz: Factores angiogénicos versus Doppler feto-materno (early GRAFD Trial).

IP: Manel Mendoza Cobaleda
Collaborators: Pablo García Manau, Erika Bonacina, Ester Del Barco Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI22/00051
Duration: 01/01/2023 - 31/12/2025

Cribado de preeclampsia en la gestación gemelar

IP: Carlota Rodó Rodríguez
Collaborators: Pablo García Manau, Berta Serrano Sanchez, Francisco Barranco Martinez, Ester Del Barco Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 162140
Reference: PI21/00601
Duration: 01/01/2022 - 30/06/2026

TISSUE ENGINEERING FOR THE IMPROVEMENT OF THE FETOSCOPIC REPAIR OF OPEN SPINAL NEURAL TUBE DEFECTS IN OVINE FETUSES (TISSUE-NTD)

IP: Nerea Maiz Elizaran
Collaborators: Ana Lain Fernandez, Margarita Codinach Creus, Silvia Arévalo Martínez, Pablo García Manau, Paula Garcia Aguilar, Susana Manrique Muñoz, Manuel López Paredes, Ester Del Barco Martínez, Erika Bonacina
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI20/00421
Duration: 01/01/2021 - 30/06/2025

EFECTO DE PROBIÓTICOS EN LA TASA DE PARTO PRETÉRMINO (< 37 semanas) EN GESTANTES DE ALTO RIESGO DE PP: GESTANTES CON AMENAZA DE PARTO PRETÉRMINO (PROPEV TRIAL)

IP: Maria del Mar Goya Canino
Collaborators: Erika Bonacina, Ester Del Barco Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 29645
Reference: PI19/00287
Duration: 01/01/2020 - 30/06/2024

Related news

Vall d’Hebron is part of the Consorcio INTERCOVID, which has analyzed over 6,500 pregnancies in 18 countries and observed a significant reduction in the risk of preeclampsia associated with vaccination.

Vall d’Hebron has taken part in a clinical trial whose results show improvements in endometrial regeneration and reproductive outcomes in patients with Asherman syndrome who had not responded to previous surgery.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Màrius Aguirre Canyadell

Màrius Aguirre Canyadell

Senior researcher
Musculoskeletal Tissue Engineering
Read more
Mohsin Riaz Akhtar

Mohsin Riaz Akhtar

Clinical Research Development Directorate
Read more
Diego Paiva Pajares

Diego Paiva Pajares

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
M Jesus Arevalo  Navines

M Jesus Arevalo Navines

Postdoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.